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Summary 25 
 26 
The goal of this study was to evaluate the role of both the % of dietary, 18-carbon PUFA 27 
(2.5%, 5% and 10%) and the n-6:n-3 ratio (1:1, 10:1 and 20:1) on the acute inflammatory 28 
response. Mice were fed diets for 8 weeks and injected intraperitoneally with LPS to induce 29 
acute inflammation. After 24 hours mice were sacrificed and plasma cytokines measured. 30 
Diets significantly affected the erythrocyte PUFA composition and the effect of PUFA ratio 31 
was more prominent than of PUFA concentration. The % dietary PUFA affected feed 32 
efficiency (p<0.05) and there was a PUFA × ratio interaction with body fat (p<0.01). In mice 33 
fed high %kcal from PUFA, those given a low n-6:n-3 ratio had more body fat than those fed 34 
a high ratio. Of the twelve cytokines measured, eleven were significantly affected by the % 35 
PUFA (p<0.05), whereas five were affected by the ratio (p<0.05). For seven cytokines, there 36 
was a significant PUFA × ratio interaction according to a two way ANOVA (p<0.05).  These 37 
data indicate that dietary polyunsaturated fatty acids can affect LPS induced-inflammation. 38 
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1. Introduction 47 
 48 
Essential fatty acids are required nutrients in animal diets because they cannot be 49 
synthesized de novo. The two 18 carbon essential fatty acids (EFA), linoleic acid (18:2n-6; 50 
LA) and linolenic acid (18:3n-3; ALA) can be further elongated and desaturated to create 51 
long chain unsaturated fatty acids such as arachidonate (20:4n-6; AA), eicosapentaenoate 52 
(20:4n-3; EPA) and docosahexenoate (22:6n-3; DHA) [1]. As the typical American diet 53 
contains a substantial excess of LA (n-6) over ALA (n-3), there is a greater proportion of AA 54 
(n-6) compared to EPA (n-3) in tissue long chain PUFA, which may influence inflammatory 55 
processes [2]. The 20 carbon PUFA species AA, EPA and dihomo-gamma-linoleate (20:3 n-6; 56 
DGLA) serve as signaling molecules (eicosanoids) when they are enzymatically released 57 
from membranes [3]. In response to stimuli, the fatty acid is cleaved from the cell membrane 58 
via a phospholipase (such as phospholipase A2)[4].  The process by which these 20 carbon 59 
fatty acids are recognized and cleaved from the membrane seems to be nonspecific for the 60 
particular class (n-6 vs. n-3) and thus the fatty acids released reflect their relative membrane 61 
proportions. The 20 carbon PUFA can then be acted upon by cyclooxygenases (COX) or 62 
lipoxygenases (LOX) which result in prostaglandins, prostacyclins and thromboxanes (COX 63 
metabolites) or leukotrienes (LOX metabolites). The net effect of eicosanoid release is 64 
complex, as it depends on the relative proportions of the different eicosanoids present, as 65 
well as the sensitivity of the tissues that sense them. In general, the eicosanoids generated 66 
from arachidonic acid (AA) are considered to be more potent mediators of inflammation 67 
than those generated from EPAs [5]. However, even COX metabolites of AA, such as PGE2 can 68 
have both pro-inflammatory and anti-inflammatory activity [5]. Thus, dietary ratios of the 69 
EFAs directly impact tissue structural lipid composition and consequently systemic 70 
inflammatory and immune processes [2].  71 
One reason intakes of EFA are so high in the US that replacing saturated fatty acids with 72 
EFA in the diet leads to lower total and LDL cholesterol levels, with LA being the most 73 
effective fatty acid in achieving this effect [6]. Thus, dietary advice given to Americans has 74 
been to replace saturated fats with foods containing more EFA. Over the last 100 years, an 75 
increase of vegetable oils in Western diets has affected both total PUFA intake and the n-6:n-76 
3 ratio. Blasbalg and colleagues [7] estimated that LA consumption increased from 2.23 to 77 
7.21% of daily calories from 1909 to 1999 and in this same time frame, the ratio of dietary 78 
n-6 to n-3 fatty acids changed from 5.4 to 9.6. It has been suggested that the increased LA 79 
intake and high n-6:n-3 ratio may negatively affect health through excessive eicosanoid 80 
signaling [8].  81 
Adding n-3 PUFA to the diet is generally considered as an effective strategy for reducing 82 
inflammation, and these molecules may affect inflammation in several ways (reviewed by 83 
Calder [4]). For example, high dietary intake of EPA results in the displacement of AA in 84 
membrane phospholipids which reduces the pool of available AA for eicosanoid synthesis. 85 
In addition, EPA inhibits the hydrolysis of AA from immune cell membranes. Furthermore, 86 
when fatty acids are cleaved from membranes enriched in EPA by PLA2, the freed EPA 87 
competes with free AA for conversion by COX and LOX enzymes. Lastly, EPA-derived 88 
eicosanoids compete with those derived from AA at target cell binding sites, and the 89 
individual eicosanoids have different effects.  While the rationale behind replacing AA with 90 
EPA is based on the weaker activity of the eicosanoids derived from EPA, there are also 91 
metabolites from EPA as well as DHA that actively promote inflammation resolution. 92 
Specialized pro-resolving mediators (SPM) is a term for lipid mediators derived from EPA 93 
and DHA that promote the active resolution of inflammation and SPM includes resolvins, 94 
protectins, and maresins [9]. Omega-3 fatty acids may also induce anti-inflammatory effects 95 
in macrophages and mature adipocytes via GPR120 signaling [10].  [11] In addition, long 96 
chain n-3 PUFA enhance B cell-mediated immunity in mice fed both control and high fat diets 97 
[11]. 98 
Most studies that have examined the inflammatory potential of dietary PUFA have 99 
focused on long chain PUFA (EPA and DHA) interventions that may not be relevant to 100 
modern, western populations.  For example, EPA and DHA intake is estimated to account for 101 
less than 0.05% of daily caloric intake compared to ~8% of daily caloric intake from plant 102 
derived LA and ALA [7].  While there is a general consensus in the literature that high intakes 103 
of n-6 fatty acids can result in a pro-inflammatory state, there are few studies in which both 104 
n-6:n-3 ratios and total PUFA concentrations have been investigated together. Moreover, 105 
most studies investigating inflammatory potential of dietary PUFA have focused on long 106 
chain n-3 interventions.   107 
The goals of this study were to determine if the total PUFA content of the diet and/or the 108 
n-6:3 ratio has an effect on the acute inflammatory response in C57BL6/J mice. 109 
Consequently, we formulated nine diets in which the fat source of the AIN-93G diet was 110 
modified to produce 3 different PUFA levels (2.5%, 5% and 10% of total kcal) at three ratios 111 
of n-6 to n-3 (1:1, 10:1 and 20:1) using fatty acids exclusively from plant sources. These PUFA 112 
concentrations, n-6 to n-3 ratios and dietary sources are physiologically relevant in the 113 
context of modern western diets, however long chain PUFA and animal fats were 114 
purposefully avoided as each may have complex actions on the inflammatory response. Mice 115 
were then challenged with LPS, a stressor that is well-known to induce an acute 116 
inflammatory response.    117 
 118 
2. Materials and Methods 119 
2.1 Diet Formulation  120 
Nine diets differing in total PUFA content and n-6 to n-3 ratios were formulated using the 121 
AIN-93G purified rodent diet. This diet has a caloric density of 3.8 kcal/g and derives 18.8 % 122 
kcal from protein, and 63.9 % kcal from carbohydrate and 17.2 % kcal from fat. Nine diets 123 
were formulated with three different PUFA levels (2.5%, 5% and 10%) at three different 124 
ratios (1:1, 10:1 and 20:1). To produce the different fat compositions, seven different 125 
vegetable oils were blended at various proportions (Table 1). Diets were produced by Harlan 126 
Laboratories (Madison, WI), and individual catalog numbers are provided in Table 1. To 127 
protect against lipid oxidation, all diets contained 14 mg/kg TBHQ and were stored at 4°C.  128 
  129 
2.2 LPS Challenge 130 
All animal experimental protocols were approved by the Utah State University Institutional 131 
Animal Care and Use Committee. Male 4-5 week old C57BL/6J mice (The Jackson Laboratory, 132 
Bar Harbor, ME) (n=12) were fed the experimental diets ad-libitum for 8 weeks.  Food intake 133 
and animal weights were determined weekly.  Three days prior to sacrifice, body 134 
composition was determined by NMR (EcoMRI LLC, Houston, TX). After 8 weeks, mice were 135 
injected intraperitoneally with 5mg/kg lipopolysaccharide (LPS, Sigma Aldrich, St. Louis, 136 
MO) 24-h prior to sacrifice and six mice were injected with saline. Mice were euthanized by 137 
CO2 asphyxiation, blood was collected via cardiac puncture, and plasma was isolated by 138 
centrifugation.  139 
 140 
2.3 Plasma Cytokine Analysis: 141 
Plasma cytokine analysis was performed using the Q-Plex™ Mouse Cytokine - Screen (16-142 
plex) array (Quansys Biosciences, Logan, UT, USA). Cytokines analyzed include: IL-1α, IL-1β, 143 
IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17, MCP-1, IFNγ, TNFα, MIP-1α, GMCSF, and 144 
RANTES.  145 
 146 
2.4 Fatty Acid Analysis 147 
Lipids were quantified in diets and red blood cells using gas chromatographic analysis of 148 
fatty acid methyl ester derivatives (FAMEs). The direct derivitization method of O’Fallon [12] 149 
was used after adaption to smaller sample sizes.  In short, diet or erythrocytes samples 150 
(~100mg) were mixed with 234 µl of 10N KOH in water and 1.77ml of methanol. Samples 151 
were vortexed for 30s and then incubated at 55 °C for 1.5h in a shaking water bath. Samples 152 
were removed every 20m and vortexed for 30s. Next, samples were cooled, and 193 µl of 153 
24N H2SO4 was added. Samples were vortexed for 30s and then incubated at 55 °C for 1.5h 154 
in a shaking water bath with vortexing every 20m for 30s. Samples were cooled and 300 µl 155 
of hexane with 0.05% BHT was added. Samples were vortexed for 30s and then centrifuged 156 
at 1000 × g for 5min. The upper hexane layer was removed to a GC vial and analyzed 157 
according to the method of Zhou et al [13] using a Shimadzu GC2010 gas chromatograph 158 
with flame ionization detection (Shimadzu Corporation, Columbia, MD). Fatty acids were 159 
separated using an HP-88 column (Agilent Corporation, Santa Clara, CA). The retention time 160 
for fatty acids and response factors were determined using GLC-463, a pure standard of fatty 161 
acid methyl esters (Nu-Chek Prep, Elysian, MN).  162 
 163 
2.5 Statistical Analysis 164 
All data were analyzed using a 2 way ANOVA with n6:n3 ratio and % dietary PUFA as the 165 
main effects. Cytokine data was normalized to plasma protein concentration, and log10 166 
transformed to adjust for non-normal distribution. After log transformation the data was 167 
normally distributed allowing for parametric testing.  168 
3. Results  169 
3.1 Fatty Acid Composition of Diets 170 
The fat sources used to create the experimental diets are shown in Table 1. The low PUFA 171 
diets contained significant proportions of low PUFA triglyceride sources, such as cocoa 172 
butter (CB) and olive oil (OO). On the other hand, the n-6 and n-3 content of the diets were 173 
primarily manipulated by including different proportions of corn oil (CO), cottonseed oil 174 
(CSO), flaxseed oil (FSO), sunflower oil (SFO), and soybean oil (SO).  175 
The measured fatty acid composition of the experimental diets is shown in Table 2. The 176 
primary focus of the diet design was to produce diets that contained different concentrations 177 
of PUFA at different ratios, yet at the same time to keep the saturated fatty acid (SFA) content 178 
similar. Therefore, the major difference between the low PUFA diets (2.5% kcal) and the high 179 
PUFA diets (10% kcal) was in the monounsaturated fatty acid content (MUFA). Despite 180 
careful formulation of the diets, the target PUFA contents and n-6:n-3 ratios were not all 181 
achieved. Nonetheless, the diets do segregate into low, medium and high PUFA contents with 182 
low, medium and high n-6:n-3 ratios.  183 
  184 
3.2 Food Consumption, Weight Gain and Body Composition 185 
The experimental diets did not significantly affect total food intake or weight gain over 186 
the course of the study (Table 3).  MRI data of body composition indicated there were no 187 
differences in lean mass, water content, but there were differences in both the absolute 188 
amount of fat (data not shown) and the relative amount (% body fat).  The differences in 189 
body composition were the result of fat mass, as there were no differences in the absolute 190 
amount of lean tissue (data not shown). In addition, there was an effect of PUFA intake on 191 
feed efficiency, which is the ratio of weight gained to food intake (Table 3; Figure 1A). 192 
When expressed as % body fat, there was an effect of the  %PUFA, the ratio and a PUFA × 193 
ratio interaction for the percent body fat of the mice after consuming the diets for 8 weeks 194 
(Table 3; Figure 1B).   Mice fed the 10% PUFA diet at the 20:1 n-6:n-3 ratio had significantly 195 
less body fat compared to those fed the same amount of PUFA but at the 1:1 n-6:n-3 ratio (P 196 
< 0.05).    197 
 198 
3.3 Effects of Diets on Red Blood Cell Fatty Acid Composition 199 
The effects of PUFA concentration and the n-6:n-3 ratio on RBC fatty acid content are 200 
shown in Table 4. Of the 19 fatty acids measured, 10 were significantly affected by the total 201 
percent PUFA in the diets, whereas 12 were affected by the n-6:n-3 ratio. According to the 202 
two-way ANOVA analysis, there was a PUFA × ratio interaction for four long chain 203 
polyunsaturates (20:4n-3, 22:5n-6, 22:5n-3 and 22:6n-3).    204 
The five most prominent fatty acids in the diets (16:0, 18:0, 18:1n9, 18:2n6 and 18:3n3; 205 
Table 2) made up between 97-98% of the dietary fat and were variable across the diets. 206 
Thus, it is not surprising all five were significantly different in the RBCs due to the PUFA 207 
percentage of the diets. One fatty acid of interest that decreased as a percentage of total 208 
RBC fatty acids with increased dietary PUFA was 20:3n9, Mead’s acid. This fatty acid is 209 
produced via elongation of oleic acid at low PUFA intakes and has been suggested as a 210 
potential biomarker for low PUFA intakes [8].  211 
As virtually all the fatty acids in the diets were <18 carbons, those in the RBCs with >18 212 
carbons were primarily synthesized via elongation and desaturation of dietary precursors. 213 
Of the thirteen fatty acids with >18 carbons, five were significantly different according to 214 
the %PUFA whereas eleven of the thirteen were different according to the n-6:n-3 ratio 215 
(Table 4).  216 
A post-hoc analysis was conducted on those fatty acids for which there was a %PUFA × 217 
ratio interaction and the results are shown in Figure 2. For EPA (20:5n-3) there were 218 
significant differences between the mice fed the 1:1 diets and those fed the 10:1 and 20:1 219 
diets. In addition, the EPA percentage of the RBCs increased at the 1:1 ratio when the mice 220 
were diets contained 5% PUFA (2.5% n-3) compared to the 2.5% PUFA(1.25% n-3), but did 221 
not increase further when the PUFA content was raised to 10% (5% n-3). The RBC 222 
percentage of Osbond acid (22:5n-6) increased with the n-6:n-3 ratio. Similar to EPA, there 223 
was an increase in the concentration when the PUFA content of the diet was increased from 224 
2.5% to 5%, but no further increase when the PUFA was at 10%. The RBC percentage of 225 
clupanodonic acid (22:5n-3) was higher in the low ratio diets (1:1) but increased as the 226 
dietary PUFA went from 2.5% of kcal to 10%. Lastly, the RBC DHA content (22:6n-3) did 227 
not differ at the low ratio (1:1) regardless of the %kcal from PUFA, but was lower at higher 228 
n-6:n-3 ratios.  229 
The omega-3 index is the sum of EPA and DHA in red blood cells, and the average values 230 
for mice in each diet group are shown at the bottom of Table 4. s According to the two way 231 
ANOVA, there is both a %PUFA and a ratio effect, but no interaction. Mice fed the 1:1 ratio 232 
of n-6:n-3 had omega-3 indices over 10, while those fed the 10:1 ratio were between 4.7 233 
and 6.2. Mice fed the high n-6:n-3 ratio diets had the lowest omega-3 indices between 3.3 234 
and 4.6.  235 
 236 
3.4 Effect of Diets on LPS Induced Systemic Inflammation  237 
Plasma cytokine data from mice given the sham injections is not shown, but there were few 238 
statistical differences between groups. Conversely, levels of all cytokines were significantly 239 
higher in mice treated with the 5 mg/kg LPS. This dose was selected to induce a vigorous, 240 
yet non-lethal inflammatory response. In a previous study in our lab, 10 mg/kg was lethal to 241 
mice in some diet groups but not others [14], despite the fact that it is regularly used to 242 
induce non-lethal inflammation [15]. Due to the distribution of the raw data, all cytokine data 243 
was log transformed prior to statistical analysis. For presentation in the figures, the data was 244 
back transformed, and is shown in mass per mg protein. Of note, IL-6, RANTES and MCP-1 245 
are all in ng/mg protein, whereas the rest are in pg/mg protein.  246 
Cytokines significantly affected by the dietary PUFA modulations are shown in Table 5 247 
and Figure 2. According to the data, 11 of the 16 cytokines measured were significantly 248 
affected by the %PUFA content of the diet, whereas 5 of 16 responded to changes in the n-249 
6:n-3 ratio. Furthermore, with 7 cytokines there was a ratio × concentration effect. The first 250 
five cytokines shown in Figure 2 (INFγ, IL-5, IL-6, IL-10 and IL-12p70) were affected by the 251 
%PUFA content of the diet, but not the ratio. For these cytokines, comparison is made at each 252 
ratio, and significant differences are designated by lower case letter, and boxes are placed 253 
around groups within each ratio. For example, for INFγ, increasing the %PUFA of the diets 254 
led to significant differences at each ratio. Thus, there was a greater INFγ response at ~10% 255 
PUFA than at 2.5% regardless of ratio. For IL-5, the response was greater in mice fed 256 
10%PUFA at the 1:1 ratio compared to mice fed 2.8% PUFA. At the 10:1 ratio mice fed the 257 
10% PUFA diets had a greater IL-5 response than mice fed the 2.5 and 5% PUFA diets. Lastly, 258 
for the high ratio, increasing the %PUFA content of the diet led to a more robust IL-5 259 
response at each level.  260 
The IL-6 response to LPS was primarily driven by the %PUFA as well. At each ratio, 261 
increasing the PUFA of the diet resulted in a more robust IL-6 response. However, there was 262 
no ratio effect and thus, the IL-6 response in the high PUFA diets was not different between 263 
the mice fed the 1:1 and 10:1 ratios at any PUFA level. For IL-10, the only significant 264 
differences were at the high ratio. Mice fed the 2.5% PUFA diet had a less robust IL-10 265 
response compared to mice fed the 5% and 10% PUFA diets. For IL-12p70 the results are 266 
similar to IL-5 and IL-6. Increasing the %PUFA content of the diet resulted in more IL-12p70, 267 
but only at the ~10% PUFA intakes.  268 
For the remaining seven cytokines measured, there was a %PUFA × ratio interaction and 269 
the post-hoc statistical analysis compared all diet groups. Consequently, in Figure 2, the 270 
arrangement of diet groups for the last seven cytokines is by %PUFA along the bottom axis. 271 
For IL-1β, there was a diminished response at the low PUFA level. Interestingly, mice fed the 272 
1:1 ratio at 10% PUFA had a greater response than mice fed the 2.5% or 5% PUFA. For IL-273 
17, the only differences were between the 2.5% PUFA and 16:1 ratio and the 10:1 and 24:1 274 
ratios at 10% PUFA. The IL-3 response pattern among diets was unique. Mice fed the 1:1 275 
ratio at 10% PUFA had a more robust response than all other diet groups. Conversely, for 276 
MIP1α, mice fed the 1:1 ratio at 10% PUFA had a lower response compared to mice fed the 277 
10% PUFA at the 10:1 and 24:1 ratio. The response of TNFα was qualitatively similar to 278 
MIP1α, in mice fed the 1:1 ratio at 10% PUFA had a lower response than mice fed the 10:1 279 
and 24:1 ratios. The other group that had a low expression of TNFα was for mice fed the low 280 
2.5% PUFA diet at a 16:1 ratio.  281 
The RANTES response to the LPS challenge was similar across all diet groups, except mice 282 
fed the low ratio, high PUFA diet. Lastly, for MCP-1, there were no differences at the low and 283 
medium PUFA intakes, but dramatic effects at the high PUFA level. At ~10% PUFA, a 10:1 284 
ratio resulted in the greatest response, followed by the 24:1 and 1:1 ratios.  285 
 286 
4. Discussion and Conclusions 287 
The goal of this study was to determine how the %kcal from LA and ALA PUFA and the n-288 
6:n-3 ratio affect the acute inflammatory response to intraperitoneal LPS injection in mice 289 
when provided on the background of the AIN-93G diet. The fat composition of the diets had 290 
a significant impact on feed efficiency and body composition despite the short feeding time. 291 
The fat composition of the diets significantly affected the RBC composition, with the 1:1 ratio 292 
diets resulting in the largest values for the omega-3 index. LPS administration caused a 293 
significant increase in all 12 cytokines measured, compared to the sham injected mice, and 294 
there were significant differences between mice fed different fat formulas. Some cytokines 295 
responded only to the %PUFA level, some to the ratio, and for some there was a %PUFA × 296 
ratio interaction.  297 
The higher level of body fat in mice fed the 10% PUFA diet at the 1:1 ratio, compared to 298 
the 24:1 ratio was a surprise. This effect was present on both an absolute and percent body 299 
composition basis. In addition, according to the MRI data, there were no differences between 300 
groups in either lean mass, or water content, which indicates the diets did not restrict 301 
growth. One reason this result was unexpected is that it has previously been shown in 302 
C57BL/6J mice that high LA diets induce adipocyte differentiation via prostacyclin signaling 303 
of AA metabolites [16]. Yet, according to Table 4, the mice with more adipose (10%PUFA, 1:1 304 
ratio) had substantially less AA in their RBC membranes than mice fed the 10% PUFA diets 305 
with a 24:1 n6:n3 ratio. One significant difference between their design, and ours, is that in 306 
the present study the diets only provided 17% of energy as fat, whereas in the study cited 307 
above it was 40%.  308 
Hanbauer et al. showed that a high n-6:n-3 ratio fed over three generations will induce 309 
obesity [17]. The low n-6:n-3 ratio diet contained 9.68% LA and 1.02% ALA, whereas the 310 
high ratio diet was 12.31% LA and 0.16% ALA. Thus, the n-6:n3 ratios were 9.5:1 and 77:1. 311 
Interestingly, the diets were less energy dense than ours, as their diets were 3.1 and 3.2 312 
kcal/g wherease ours were 3.9 kcal/g. One other notable difference is that they used B6C3Fe 313 
mice. Massiera et al. also showed that mice fed a high n-6:n-3 ratio diet became gradually 314 
more obese over four generations [18]. However, one major issue with this study is that the 315 
high n-6 diet had 3X the amount of fat as the control diet. Thus, it is not clear what the 316 
primary driver of fat mass was over successive generations.  317 
Alvheim et al. also found that increasing the dietary intake of LA was associated with more 318 
adipose gain [19]. C57BL/6j mice were fed either moderate (35% kcal) or high-fat (60% 319 
kcal) diets for 14 weeks. The diets contained either 1% or 8% of calories as LA, and ALA was 320 
held constant at 1% of calories. In addition, a third group was fed 8% LA and had an 321 
additional 1% of a mixture of EPA and DHA. Their results indicated that high LA induced 322 
obesity via increases in the proportion of AA in liver and erythrocyte phospholipids and 323 
associated endocannabinoid signaling. In a separate study using similar LA and ALA 324 
treatments on a low fat diet, Alvheim et al found that 8% LA caused greater weight gain over 325 
1% ALA. However, there were no differences when the same PUFA treatments were 326 
presented in medium fat diets (35% kcal from fat). In both the studies by Alvheim, higher 327 
intakes of LA increased feed efficiency. We found a %PUFA effect on feed efficiency, but no 328 
ratio effect (Table 3; Figure 2). Other groups have not found an effect of high LA intakes and 329 
high n-6:n-3 ratios on obesity and weight gain. For example, Enos et al. fed mice diets 330 
composed of 40% kcal by fat where n-6 fatty acids comprised 4.7%, 7.8%, 8.6% and 9% kcal  331 
[20]. By also changing the n-3 content the diets had 1:1, 5:1, 10:1 and 20:1 ratios of n-6 to n-332 
3. In contrast to the other studies described above, there was no effect of the different fat 333 
formulas on weight gain, visceral adipose mass, or adipocyte size, despite significant effects 334 
on the ratios of AA and both EPA and DHA in adipose phospholipids. While there may be an 335 
effect of higher LA intakes on weight gain and adiposity in some animals and on some diet 336 
backgrounds, the results are not consistent.  337 
Populations that consume increased amounts of n-3 fatty acids appear to receive 338 
protection from some pathologies associated with inflammation, advice given to individuals 339 
is to change the n-6 to n-3 ratio by eating more oily fish, and other foods rich in n-3s like flax 340 
seed oil. In the diet of early humans, the estimated ratio of n-6 to n-3 fatty acids was 0.8:1, 341 
yet in some contemporary populations the ratio has increased to ~17:1 [21], presumably 342 
due to the increased consumption n-6 rich vegetable oils and decreased fish consumption 343 
[2].  In our LPS challenge model, increased dietary PUFA concentration had a strong 344 
stimulatory effect on several plasma cytokines regardless of n-6 to n-3 ratio including IL-1, 345 
IL-5, IL-6, IL-10, IL-12p70, IL-17 and INF-γ and the dietary n6n-6 to n-3 PUFA ratios affected 346 
MCP-1, TNF-α, MIP-1α and RANTES.  Our data suggests that the total amount of dietary PUFA 347 
may be an important determinant in the acute LPS inflammatory response and the n-6 to n-348 
3 ratio may only be important at higher concentrations of total dietary PUFA. 349 
In recent years it has been suggested that a high n-6 intake and high n-6:n-3 ratio promote 350 
the pathogenesis of many diseases [20]. The link between increased n-6 intake, inflammation 351 
and disease progression is based on the idea that higher dietary intakes of LA will increase 352 
cellular pools of AA, and will promote a more inflammatory cytokine response [21]. Yet, 353 
despite this supposition, in humans consuming Western-type diets, plasma AA is resistant to 354 
large changes in dietary LA [22]. In addition, while human peripheral blood mononuclear 355 
cell PUFA composition does affect immune function, the LA, ALA, AA, EPA and DHA levels do 356 
not necessarily correlate with dietary intake [23]. Furthermore, in a cross-sectional analysis 357 
of plasma PUFA levels and inflammatory markers, the lowest quartile of n-6 PUFA was 358 
associated with the highest concentration of TNFα and Il-6 [24].  Because the n-6:n-3 ratio is 359 
driven by both n-6 and n-3 consumption, effects will be affected by both the total and relative 360 
intakes.  361 
Several studies have investigated the effects of dietary n-3 on systemic inflammation but 362 
the focus of the majority of these studies has been on long chain n-3 fatty acids, primarily 363 
EPA and DHA. Our data suggest that dietary intake and relative ratios of plant derived n-6 364 
and n-3 fatty acids have profound effects on the LPS induced inflammatory response. Very 365 
few studies have investigated the effects of dietary n-6 and n-3 fatty acids on acute, LPS 366 
initiated inflammation and to our knowledge, no studies have investigated the relative 367 
contributions of both total PUFA concentration and ratios of n-6 to n-3.  Chavali et al. [22] 368 
injected Balb/c mice with a lethal dose (20 mg/kg) of LPS.  Mice were fed either safflower oil 369 
diets or safflower + linseed oil diets.  The fat content of the safflower oil diets was 79.4% LA 370 
or ~24% of total energy with negligible ALA.  The safflower + linseed oil diet contained 371 
approximately equal LA and ALA, approximately 12% of total dietary energy for each fatty 372 
acid.  Plasma levels of IL-6 were higher in the LA fed animals compared to the LA + ALA fed 373 
mice while TNF-α levels were higher in the LA + ALA animals.  Although in our study much 374 
lower levels of dietary PUFA were fed, we found that that decreasing the n-6 to n-3 ratio by 375 
incorporating dietary ALA decreases LPS induction of plasma TNF-α. In a previous LPS 376 
challenge study by our group [23], mice were fed either the AIN-76 diet or a modified AIN-377 
76 diet that replaced the corn oil fat source with dairy lipids.   The dairy lipid diet contained 378 
only 0.6% of calories from PUFA and had had an n-6 to n-3 ratio of 9.4.  Conversely, the corn 379 
oil fat sourced AIN-76 diet contained 6.9% of calories from PUFA and n-6 to n-3 ratio of 56.4.   380 
Similar to the current study, mice fed the lower PUFA, lower n-6 to n-3 ratio diet had 381 
significantly lowered levels of plasma IL-6, IL-3, IL-10, IL-17, MCP-1, IFN-, TNF- and IL-382 
12p70. 383 
The effects of dietary LA and ALA have been investigated in other models of acute 384 
inflammation, including chemically induced colitis.  In a recent study [24], colitis was 385 
induced in rats fed either corn oil or an ALA rich camelina oil diet.  Rats fed the ALA rich diet 386 
had lowered colonic expression of IL-1 and TNF-.  Similarly, in a study by Tyagi and 387 
coworkers [25] rats were fed differing n-6 to n-3 ratios by manipulating dietary LA and ALA 388 
levels varying from 215:1, 50:1, 10:1 and 2:1.  Inflammatory colitis was induced by dextran 389 
sodium sulfate treatment.  Colonic expression of both IL-1 and TNF- was lowest at the 2:1 390 
ratio.  In our study, the n-6 to n-3 ratio significantly affected plasma levels of TNF- however, 391 
plasma IL-1 were not responsive to the PUFA ratio and increased as a function of total 392 
dietary PUFA.   393 
The inflammatory response to LPS is mediated through the LPS receptor, Toll-like 394 
receptor 4 (TLR4).  Circulating LPS is bound by the secreted LPS binding protein (LBP) and 395 
then can form a complex with CD14 and interact TLR4 to initiate a signaling cascade that 396 
results in the degradation of IB and binding of NF-B to the promoters of immune response 397 
genes [26].  NF-κB is a ubiquitously expressed transcription factor that mediates the 398 
inflammatory response to a diverse set of signals including LPS. Activation of NF-κb involves 399 
translocation from the cytosol to the nucleus after disassociation from the inhibitory subunit 400 
IκB. The resulting signaling causes increased expression of several inflammatory cytokines 401 
including TNF-, IL-1, IL-6 and INF-.  Fatty acids are known to play a role in the NF-κB 402 
signaling pathway. Zhao et al (2004) demonstrated that EPA inhibited NF-κB inflammatory 403 
activation by preventing the phosphorylation of IκB in THP-1 cells and inhibited NF-κb 404 
activation similar to DHA in LPS induced THP-1 cells [27, 28]. Inhibition of NF-κB activation 405 
by fish oil has also been reported in RAW 267.4 macrophages [28]. Lee and coworkers [29] 406 
demonstrated that DHA and EPA are the most potent inhibitors of LPS induced NF-κb 407 
activation in RAW 264.7 mouse monocytes.  However, arachidonic, linoleic and oleic acid 408 
also inhibited NF-κb activation compared to cells treated with lauric acid. Fatty acids are also 409 
thought to influence inflammatory pathways by acting as ligands for PPARγ.  PPARγ is 410 
expressed in many tissues including adipose, muscle, and vascular cells. Activated PPARγ 411 
induces lipoprotein lipase and fatty acid transporters and enhances adipocyte differentiation 412 
as well as inhibiting NF-κB function, cytokine and COX-2 expression. Acting as a PPARγ 413 
ligand, EPA has been demonstrated to attenuate expression of IL-6 in C6 glioma cells [30] 414 
and Caco-2 intestinal cells [31]. 415 
It is not clear why the diets lowest in PUFA generally resulted in less inflammation in the 416 
current study.  Animals fed the 2.5% PUFA diets at the 10:1 and 24:1 rations did not have 417 
lower levels of AA or higher levels of EPA or DHA as RBC fatty acids compared to the 10% 418 
PUFA diets.  Therefore, our data suggests that the reduced inflammation observed in the low 419 
PUFA compared to the high PUFA diets may be independent from conversion of LA to AA or 420 
ALA to EPA and DHA.  421 
Taken together, our data suggest that the most commonly consumed n-3 and n-6 fatty 422 
acids in modern diets, LA and ALA, play an important role in the susceptibility to acute 423 
inflammatory stressors.  Current public health recommendations have stressed the 424 
importance of lowering the n-6 to n-3 ratio and incorporating long chain n-3 fatty acids such 425 
as EPA and DHA into diets.  By designing a study to determine the inflammatory potential of 426 
both dietary PUFA concentration and n-6 to n-3 ratio using PUFA sources relevant to modern 427 
diets; we have found that total dietary PUFA concentration must be considered as an 428 
important factor in acute inflammation.  This finding may have implications for conditions 429 
such as sepsis and bacterial infections.  However, the molecular mechanisms as to how 430 
different concentrations and ratios of dietary LA and ALA influence LPS mediated 431 
inflammation are not known.  Future work examining the effects of these diets on candidate 432 
pathways such as expression of toll like receptors, NF-B and PPAR-, and on PUFA-derived 433 
lipid mediators is warranted.                     434 
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Table 1: Fat formulas for experimental diets.  Values are expressed as a percentage of total dietary fat.  
Abbreviations are: Cocoa butter (CB), corn oil (CO), cottonseed oil (CSO), flaxseed oil (FSO), olive oil (OO), 
sunflower oil (SFO) and soybean oil (SO). The diets were prepared by Harlan Laboratories (Madison, WI) and 
the catalog numbers are given in the table.  
Diet Target %PUFA n-6:n-3 Ratio CB CO CSO FSO OO SFO SO Catalog # 
1 2.5 1:1 45.5 -- -- 12.5 42.0 -- -- TD.10148 
2 2.5 10:1 29.5 11.0 -- 15.5 58.0 -- -- TD.10149 
3 2.5 20:1 23.0 9.5 -- -- 65.0 -- 2.5 TD.10150 
4 55                             5 1:1 45.0 -- -- 23.0 15.5 -- 16.5 TD.10151 
5 5 10:1 26.2 39.0 -- 3.8 31.0 -- -- TD.10152 
6 5 20:1 15 -- 30.0 -- 42.0 -- 13.0 TD.10153 
7 10 1:1 8.0 -- 40.0 52.0 -- -- -- TD.10154 
8 10 10:1 -- -- 79.4 9.1 -- 11.5 -- TD.10155 
9 10 20:1 -- -- 65.5 4.5 5.0 25.0 -- TD.10156 
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Table 2.  Fatty acid composition of diets.   Values are expressed as a percentage of total dietary energy. 
 Target Values Measured Values 
Diet PUFA% Ratio 16:0 18:0 18:1n9 18:2n6 18:3n3 SFA MUFA PUFA ratio 
1 2.5   1:1 2.8±.1 2.8±.1 8.4±.1 1.5±.1 1.4±.1 5.6 8.4 2.8 1:1 
2 2.5   10:1 2.5±.1 2.0±.2 9.8±.1 2.3±.1 0.3±.1 4.5 9.8 2.5 9:1 
3 2.5   20:1 2.4±.1 1.7±.1 10.2±.1 2.4±.1 0.2±.1 4.1 10.2 2.5 16:1 
4 5   1:1 2.6±.1 3.5±.2 6.2±.4 2.6±.4 2.0±.7 6.1 6.2 4.5 1:1 
5 5   10:1 2.4±.1 2.0±.3 7.5±.2 4.5±.3 0.5±.1 4.4 7.5 5 10:1 
6 5   20:1 2.6±.1 1.4±.2 7.9±.2 4.8±.3 0.3±.1 3.9 7.8 5 18:1 
7 10   1:1 2.2±.1 1.1±.3 3.7±.4 5.3±.2 4.8±.7 3.3 3.7 10 1:1 
8 10   10:1 2.8±.1 0.5±.1 3.4±.1 9.2±.2 0.9±.1 3.3 3.4 10 10:1 
9 10   20:1 2.7±.2 0.8±.2 4.5±.5 8.5±.8 0.4±1 3.5 4.5 8.8 24:1 
 590 
  591 
Table 3: Results of two way ANOVA for food intake, weight gain, and body composition. 
 % PUFA Ratio Interaction 
 p value 
Food intake 0.46 0.11 0.34 
Weight gain 0.08 0.36 0.12 
Feed efficiency 0.04 0.43 0.13 
Percent body fat 0.06 <0.01 <0.01 
 592 
593 
 594 
Figure 1: Feed efficiency ratio (A) and percent body fat (B) of mice fed nine experimental diets. There 595 
was a significant effect of PUFA on the feed efficiency ratio (p=0.4), but no n-6:n-3 ratio effect or 596 
interaction in the two way ANOVA (A). For body fat there was both a ratio effect (p<0.01) and a PUFA × 597 
ratio interaction (p<0.01) as determined by the two way ANOVA. Groups with the same letter are not 598 
significantly different according to the Tukey HSD test.   599 
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 Table 4: Fatty acid composition of erythrocytes (in percent) from mice fed 9 diets differing in %PUFA and the n-6:n-3 ratio.  
PUFA 
%kcal 
2.8% 2.5% 2.5% 4.5% 5% 5% 10% 10% 8.8% p values for 2 × 2 ANOVA 
n-6:n-3 
ratio 
1:1 9:1 16:1 1:1 10:1 18:1 1:1 10:1 24:1 PUFA Ratio Interaction‡ 
16:0 25.2±0.6 24.6±1.2 24.1±0.2 26.3±0.5 24.4±0.8 24.8±0.5 26.1±0.7 27.3±2.1 26.5±1.4 <0.01 NS NS 
16:1n-7 2.6±0.7 2.0±1.0 2.5±0.4 1.7±0.3 2.3±0.3 2.2±0.1 2.3±0.6 2.4±0.5 2.0±0.8 NS NS NS 
18:0 12.6±0.3 12.6±0.3 12.3±0.3 13.7±0.1 13.6±0.6 13.4±0.2 13.6±0.7 12.6±0.8 13.0±0.1 <0.01 NS NS 
18:1n-9 22.3±1.4 21.6±1.4 21.3±0.7 17.4±0.1 17.3±0.5 18.0±0.4 14.3±0.6 12.3±0.8 11.9±0.4 <0.01 0.04 NS 
18:2n-6 6.1±0.3 6.2±0.4 6.5±0.3 8.8±0.2 7.8±0.6 8.0±0.1 11.7±0.4 11.6±0.6 12.0±0.4 <0.01 NS NS 
18:3n-3 1.4±0.2 1.1±0.6 1.0±0.1 1.6±0.2 1.6±0.2 1.4±0.3 2.0±0.5 1.8±0.7 1.8±0.6 <0.01 NS NS 
20:0 0.4±0.1 0.5±0.2 0.7±0.4 0.2±0.1 0.4±0.1 0.4±0.1 0.4±0.1 0.4±0.1 0.4±0.2 NS NS NS 
20:1n-9 0.6±0.2 0.8±0.2 0.7±0.1 0.4±0.2 0.8±0.3 0.5±0.1 0.4±0.1 0.8±0.3 0.7±0.4 NS 0.03 NS 
20:3n-9 0.8±0.1 1.2±0.1 1.1±0.1 0.2±0.1 0.3±0.01 0.3±0.1 0.2±0.1 0.3±0.1 0.2±0.2 <0.01 <0.01 NS 
20:3n-6 1.4±0.2 1.7±0.1 1.8±0.3 1.3±0.2 1.6±0.1 1.5±0.1 1.4±0.1 1.7±0.1 1.6±0.3 NS <0.01 NS 
20:4n-6 12.1±0.8 18.3±1.0 19.6±0.5 12.5±0.3 18.9±0.6 19.8±0.4 11.8±0.4 17.7±0.5 18.8±0.8 0.02 <0.01 NS 
20:5n-3 2.3±0.3B 0.3±0.1C 0.2±0.1C 2.9±0.1A 0.5±0.5 C 0.1±0.02C 3.0±0.2A 0.3±0.1C 0.1±0.02C 0.03 <0.01 0.01 
22:0 0.2±0.1 0.2±0.1 0.1±0.1 0.1±0.01 0.4±0.4 0.1±0.01 0.05±0.06 0.3±0.2 0.1±0.1 NS 0.04 NS 
22:4n-6 0.7±0.1 2.1±0.2 2.2±0.1 0.6±0.4 2.2±0.1 2.4±0.1 0.6±0.1 2.0±0.2 2.7±0.4 NS <0.01 NS 
22:5n-6 0.2±0.02D 1.7±0.1C 2.2±0.2B 0.2±0.03D 1.5±0.1C 2.7±0.2A 0.1±0.04D 1.5±0.1C 2.7±0.2A NS <0.01 <0.01 
22:5n-3 1.7±0.1C 0.4±0.1D,E 0.2±0.1E 2.2±0.1B 0.5±0.4D,E 0.3±0.03D,E 2.7±0.1A 0.7±0.02D 0.5±0.1D,E <0.01 <0.01 <0.01 
22:6n-3 8.9±0.8A 4.4±0.4C 3.2±0.1D 9.6±0.1A 5.4±0.5B,C 3.8±0.2C,D 9.1±0.3A 6.0±0.3B 4.5±0.4C <0.01 <0.01 0.02 
24:0 0.2±0.03 0.2±0.1 0.1±0.03 0.2±0.1 0.2±0.0 3 0.2±0.03 0.2±0.01 0.2±0.03 0.2±0.04 NS 0.01 NS 
24:1n-9 0.3±0.1 0.2±0.1 0.2±0.2 0.2±0.1 0.2±0.1 0.1±0.02 0.1±0.02 0.2±0.1 0.1±0.03 NS NS NS 
Ω-3 index 11.3±1.0 4.7±0.4 3.3±0.1 12.5±0.1 5.9±0.9 3.8±0.2 12.0±0.4 6.2±0.4 4.6±0.4 <0.01 <0.01 NS 
‡The 2 × 2 ANOVA indicated there were four fatty acids that had a %PUFA × ratio interaction (20:5n3, 22:5n6, 22:5n3, and 22:6n3). Superscripts 
indicated fatty acids that are significantly different according to the Tukey HSD test.  
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Table 5: Two-way ANOVA analysis of effects of dietary PUFA concentration and n-6:n-3 ratios on plasma 
cytokines in mice treated with LPS. 
Cytokine % PUFA n-6:n-3 ratio Interaction 
INFγ <0.01 NS NS 
Il-5 <0.01 NS NS 
Il-6 <0.01 NS NS 
Il-10 <0.01 NS NS 
ll-12p70 <0.01 NS NS 
IL-1β <0.01 NS 0.02 
Il-17 <0.01 NS <0.01 
Il-3 <0.01 <0.01 <0.01 
MIP1-α 0.03 0.05 <0.01 
TNFα 0.05 <0.01 <0.01 
RANTES <0.01 <0.01 <0.01 
MCP-1 NS <0.01 <0.01 
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Figure 2: Effect of diets on plasma cytokines 24h after acute LPS administration. Cytokines 3 
were analyzed using a two way ANOVA and significance differences further explored using 4 
the Tukey HSD test. For cytokines A-E there is an effect of PUFA, but no ratio effect nor an 5 
interaction. Lower case letters for these cytokines are only comparable within a PUFA level 6 
(2.5%, 5%, 10%). For cytokines F-L there was a PUFA × ratio interaction, and upper case 7 
letter indicate differences between treatments.  8 
9 
